CD11c + B cells in relapsing-remitting multiple sclerosis and effects of anti-CD20 therapy.
Sahla El MahdaouiMarie Mathilde HansenMarina Rode von EssenVictoria Hyslop HvalkofRikke Holm Holm HansenMie Reith MahlerPoul Jørgen JennumFinn SellebjergJeppe Romme ChristensenPublished in: Annals of clinical and translational neurology (2024)
B cells comprise a phenotypically and functionally distinct, albeit heterogenous, B-cell subset with the capacity of exerting both proinflammatory and regulatory functions.